{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:49:48Z","timestamp":1789609788595,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ijcard.2023.03.054","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T08:39:23Z","timestamp":1680165563000},"page":"101-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion"],"prefix":"10.1016","volume":"381","author":[{"given":"Massimo","family":"Volpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cianflone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cittadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Perrone","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijcard.2023.03.054_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023667","article-title":"Body mass index and association with cardiovascular outcomes in patients with stable coronary heart disease \u2013 a STABILITY substudy","volume":"11","author":"Held","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-319-48382-5_9","article-title":"The pathogenesis of obesity-associated adipose tissue inflammation","volume":"960","author":"Engin","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"19","key":"10.1016\/j.ijcard.2023.03.054_bb0015","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/ AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"JACC"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0020","first-page":"824","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V survey registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"EJPC"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijcard.2023.03.054_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation. A Meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"10.1016\/j.ijcard.2023.03.054_bb0035","first-page":"142","article-title":"The epidemic of obesity and diabetes - trends and treatments","volume":"38","author":"Barnes","year":"2011","journal-title":"Tex Heart Inst J"},{"issue":"3","key":"10.1016\/j.ijcard.2023.03.054_bb0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.11114\/ijsss.v2i3.439","article-title":"Obstructive sleep apnea and multiple anthropometric indices of general obesity and abdominal obesity among young adults","volume":"2","author":"Chen","year":"2014","journal-title":"Int J Soc Sci Stud"},{"issue":"22","key":"10.1016\/j.ijcard.2023.03.054_bb0045","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/CIRCULATIONAHA.107.762229","article-title":"ALLHAT collaborative research group. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial","volume":"118","author":"Davis","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2023.03.054_bb0050","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCHEARTFAILURE.113.000383","article-title":"Longitudinal changes in left ventricular stiffness: a community-based study","volume":"6","author":"Borlaug","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ijcard.2023.03.054_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2014.03.014","article-title":"Impact of general and central adiposity on ventricular-arterial aging in women and men","volume":"2","author":"Wohlfahrt","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ijcard.2023.03.054_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.ijcard.2023.03.054_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.768119","article-title":"Obesity and cardiovascular disease: the emerging role of inflammation","volume":"8","author":"Khafagy","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0070","unstructured":"Orlistat SmPC."},{"issue":"1","key":"10.1016\/j.ijcard.2023.03.054_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.ijcard.2023.03.054_bb0080","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.2337\/dc13-0234","article-title":"Effects of naltrexone sustained-release\/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes","volume":"36","author":"Hollander","year":"2013","journal-title":"Diabetes Care"},{"issue":"375","key":"10.1016\/j.ijcard.2023.03.054_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"28","author":"Marso","year":"2016","journal-title":"N Eng J M"},{"issue":"9","key":"10.1016\/j.ijcard.2023.03.054_bb0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","article-title":"Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial","volume":"9","author":"Neeland","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.ijcard.2023.03.054_bb0095","unstructured":"Liraglutide SmPC."},{"issue":"6","key":"10.1016\/j.ijcard.2023.03.054_bb0100","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/oby.22794","article-title":"Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5","volume":"28","author":"Kushner","year":"2020","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.ijcard.2023.03.054_bb0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly Semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"10278","key":"10.1016\/j.ijcard.2023.03.054_bb0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 24 mg once a week in adults with over- weight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double- dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0115","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"STEP 3 investigators. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with over- weight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.ijcard.2023.03.054_bb0120","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous Semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ijcard.2023.03.054_bb0125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"STEP 1 study group. Once-weekly Semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.amjcard.2022.04.030","article-title":"Meta-analysis assessing the cardiovascular safety of Semaglutide for the treatment of overweight or obesity","volume":"175","author":"Patoulias","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2023.03.054_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ahj.2020.07.008","article-title":"Semaglutide effects on CV outcomes in people with overweight or obesity (SELECT) rationale and design","volume":"229","author":"Ryan","year":"2020","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.ijcard.2023.03.054_bb0140","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/oby.2001.108","article-title":"Bias, discrimination, and obesity","volume":"9","author":"Puhl","year":"2001","journal-title":"Obes Res"}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2023.131402","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323004655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323004655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T04:30:26Z","timestamp":1693974626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323004655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":28,"alternative-id":["S0167527323004655"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.054","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijcard.2023.131402","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How cardiologists can manage excess body weight and related cardiovascular risk. An expert opinion","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}